相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents
Raul C. Maranhao et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella
Danielle Cristinne Azevedo Feio et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages
Chun Gu et al.
FRONTIERS IN PHYSIOLOGY (2017)
Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles
Elaine N. Daminelli et al.
CARDIOVASCULAR DRUGS AND THERAPY (2016)
Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles
Afonso A. Shiozaki et al.
CLINICS (2016)
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
Simon Barquera et al.
ARCHIVES OF MEDICAL RESEARCH (2015)
Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Raul C. Maranhao et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Advances in non-invasive drug delivery for atherosclerotic heart disease
Raul C. Maranhao et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties
Shuang-shuang Wang et al.
PLOS ONE (2015)
Mechanisms of Plaque Formation and Rupture
Jacob Fog Bentzon et al.
CIRCULATION RESEARCH (2014)
Anti-Atherogenic Effects of Methotrexate Carried by a Lipid Nanoemulsion That Binds to LDL Receptors in Cholesterol-fed Rabbits
Adriana Bulgarelli et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
TNF-α signalling and inflammation: interactions between old acquaintances
Hana Zelova et al.
INFLAMMATION RESEARCH (2013)
Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits
Vivek Khanna et al.
PLOS ONE (2013)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Tumor Necrosis Factor-a Signaling in Macrophages
Narayanan Parameswaran et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
Methotrexate-how does it really work?
Edwin S. L. Chan et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study
Luis A. Pires et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability
Andrew C. Newby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit
Raul C. Maranhao et al.
ATHEROSCLEROSIS (2008)
Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers
Maria L. N. Dias et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE
KV Pinheiro et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion
Ana C. Lo Prete et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion:: in vitro and in vivo studies
DG Rodrigues et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma
CHM Azevedo et al.
GYNECOLOGIC ONCOLOGY (2005)
Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE)
RS Teixeira et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease
VTM Hungria et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients
RC Maranhao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
